220 related articles for article (PubMed ID: 18931493)
1. Cryptogenic emboli in patients with patent foramen ovale or atrial septal defect associated with the use of nonsteroidal anti-inflammatory drugs.
Ferguson MA; Mackay SM; Ramchandani SR; Thurber JS; Curran MJ; DeGraba TJ
Cardiology; 2009; 113(1):20-4. PubMed ID: 18931493
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
Bannan A; Shen R; Silvestry FE; Herrmann HC
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
[TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale and cryptogenic stroke in older patients.
Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
[TBL] [Abstract][Full Text] [Related]
6. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
Rigatelli G; Giordan M; Braggion G; Aggio S; Chinaglia M; Zattoni L; Milan T; Cardaioli P
Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946
[TBL] [Abstract][Full Text] [Related]
7. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
[TBL] [Abstract][Full Text] [Related]
9. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
[TBL] [Abstract][Full Text] [Related]
10. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
11. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes.
Delabays C; Correia P; Eeckhout E; Delabays A; Michel P
J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale.
Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
Int J Cardiol; 2007 Sep; 120(3):357-62. PubMed ID: 17166607
[TBL] [Abstract][Full Text] [Related]
13. Patent foramen ovale complicated by paradoxical embolism and brain infarct in a patient with advanced ovarian cancer.
Mitsui T; Aoki Y; Nagata Y; Kojima Y; Tanaka K
Gynecol Oncol; 2001 Dec; 83(3):608-9. PubMed ID: 11733982
[TBL] [Abstract][Full Text] [Related]
14. PFO and paradoxical embolism producing events other than stroke.
Dao CN; Tobis JM
Catheter Cardiovasc Interv; 2011 May; 77(6):903-9. PubMed ID: 21207422
[TBL] [Abstract][Full Text] [Related]
15. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
16. Cryptogenic stroke and patent foramen ovale.
Thaler DE; Saver JL
Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation.
Attenhofer Jost CH; Connolly HM; Scott CG; Burkhart HM; Ammash NM; Dearani JA
Congenit Heart Dis; 2014; 9(1):30-7. PubMed ID: 23601093
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary embolism associated with paradoxical arterial embolism in a patient with patent foramen ovale].
Maffè S; Dellavesa P; Perucca A; Paffoni P; Paino AM; Zanetta M
G Ital Cardiol (Rome); 2008 Sep; 9(9):637-40. PubMed ID: 18783084
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure.
Dodge SM; Hassell K; Anderson CA; Keller J; Groves B; Carroll JD
Catheter Cardiovasc Interv; 2004 Jan; 61(1):123-7. PubMed ID: 14696171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
